ENANTIOSELECTIVE KINETICS OF VERAPAMIL AND NORVERAPAMIL IN ISOLATED-PERFUSED RAT LIVERS

被引:21
作者
MEHVAR, R [1 ]
REYNOLDS, JM [1 ]
ROBINSON, MA [1 ]
LONGSTRETH, JA [1 ]
机构
[1] GD SEARLE & CO,SKOKIE,IL 60077
关键词
VERAPAMIL; NOVERAPAMIL; STEREOSELECTIVE METABOLISM; ISOLATED PERFUSED RAT LIVER; METABOLITE KINETICS; FIRST-PASS METABOLISM;
D O I
10.1023/A:1018935921473
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The kinetics of the individual enantiomers of verapamil (VER) and its metabolite, norverapamil (NOR), were studied in isolated perfused rat livers (IPRLs) after administration of racemic drug or the preformed metabolite. After constant infusion of 20 mu g/min of racemic VER to single-pass IPRLs, the hepatic availabilities (F) of the enantiomers were low (S-VER, 0.069 +/- 0.030; R-VER: 0.046 +/- 0.025) and stereoselective (S:R ratio, 1.6 +/- 0.2). After administration of similar doses, the F values of the preformed NOR enantiomers (S-NOR: 0.24 +/- 0.04; R-NOR, 0.10 +/- 0.02) were higher than those of the VER enantiomers. However, the stereoselectivity in F of NOR (S:R ratio, 2.2 +/- 0.1), was in the same direction of that of VER. Further, the fractions of R enantiomers unbound to bovine serum albumin in the perfusate were higher than those of their antipodes for both VER (R:S ratio, 1.9 +/- 0.1) and NOR (R:S ratio, 2.6 +/- 0.2). Therefore, for unbound moieties, modest stereoselectivity in the metabolism of VER in favor of the S-isomer and no stereoselectivity in the metabolism of NOR were observed. Overall, our data suggest that the stereoselective protein binding is a primary determinant of stereoselectivity in the hepatic availability of VER and NOR in IPRLs.
引用
收藏
页码:1815 / 1819
页数:5
相关论文
共 22 条
  • [1] ABERNETHY DR, 1993, J PHARMACOL EXP THER, V266, P904
  • [2] PHARMACOKINETICS OF THE ENANTIOMERS OF VERAPAMIL IN THE DOG
    BAI, SA
    LANKFORD, SM
    JOHNSON, LM
    [J]. CHIRALITY, 1993, 5 (06) : 436 - 442
  • [3] CASHMAN JR, 1989, MOL PHARMACOL, V36, P497
  • [4] ELECTROPHYSIOLOGIC EFFECTS OF DEXTRO-VERAPAMIL AND LEVO-VERAPAMIL ON SINUS NODE AND AV NODE FUNCTION IN HUMANS
    ECHIZEN, H
    MANZ, M
    EICHELBAUM, M
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (05) : 543 - 546
  • [5] THE PHARMACOKINETICS AND PHARMACODYNAMICS OF D-VERAPAMIL AND DL-VERAPAMIL IN RABBITS
    GIACOMINI, JC
    NELSON, WL
    THEODORE, L
    WONG, FM
    ROOD, D
    GIACOMINI, KM
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (03) : 469 - 475
  • [6] CLINICAL PHARMACOKINETICS OF VERAPAMIL
    HAMANN, SR
    BLOUIN, RA
    MCALLISTER, RG
    [J]. CLINICAL PHARMACOKINETICS, 1984, 9 (01) : 26 - 41
  • [7] HUSSAIN MD, 1994, DRUG METAB DISPOS, V22, P36
  • [8] KROEMER HK, 1992, J PHARMACOL EXP THER, V260, P1052
  • [9] INTRAVENOUS VERAPAMIL KINETICS IN RATS - MARKED ARTERIOVENOUS CONCENTRATION DIFFERENCE AND COMPARISON WITH HUMANS
    MANITPISITKUL, P
    CHIOU, WL
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1993, 14 (07) : 555 - 566
  • [10] MCALLISTER RG, 1977, J PHARMACOL EXP THER, V202, P38